This protocol is judged by an institutional critique board, an impartial team that reviews any scientific trials involving individuals. If a study will involve a Timetable I drug, once the board approves the protocol as ethical, the scientists need to submit an application for an investigational new drug (IND) quantity with the FDA.And since the co